Ankylosing Spondylitis Trial, Recruiting NCT07166874 Sponsor: Saglik Bilimleri Universitesi Condition: Ankylosing Spondylitis
Back to Ankylosing Spondylitis

Ankylosing Spondylitis Trial, Recruiting

NCT07166874
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with axial spondyloarthritis (a type of inflammatory spinal condition) based on recognised medical criteria (confirm with trial site)
  • You are between 18 and 64 years old
  • You have been on a stable medication plan (such as anti-inflammatory or disease-modifying drugs) for at least 3 months
  • You are willing and able to give written consent and follow the study requirements

Who may not be able to join:

  • You are currently following a specific diet, or have been on one within the last 3 months
  • You have a history of coeliac disease (a condition where gluten causes gut damage)
  • You have a history of Ulcerative Colitis, Crohn's Disease, or Irritable Bowel Syndrome (conditions affecting the digestive system)
  • You have Type 1 or Type 2 Diabetes
  • You have Hashimoto's Thyroiditis (an immune condition affecting the thyroid gland)
  • You are currently pregnant or breastfeeding
  • You have regularly taken omega-3 supplements or vitamins A, C, or E in the last 3 months
  • Your Body Mass Index (BMI) is below 18.50 (considered underweight range)
  • Your Body Mass Index (BMI) is 29.99 or above (considered overweight to obese range)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +902124147171

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Saglik Bilimleri Universitesi
Registry
ClinicalTrials.gov
Start date
31 January 2025
Est. completion
30 December 2025

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

effects of a 8-week Gluten Free Diet versus placebo diet on fasting serum zonulin levels; effects of a 8-week Gluten Free Diet versus placebo diet on fasting serum LPS levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov